degarelix accord
accord healthcare s.l.u. - degarelix acetate - prostata-neoplasmen - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
quetiapin accord 300 mg filmtabletten
accord healthcare limited (8093024) - quetiapinfumarat (ph.eur.) - filmtablette - quetiapinfumarat (ph.eur.) (30625) 345,36 milligramm
quetiapin accord 200 mg filmtabletten
accord healthcare limited (8093024) - quetiapinfumarat (ph.eur.) - filmtablette - quetiapinfumarat (ph.eur.) (30625) 230,24 milligramm
quetiapin accord 25 mg filmtabletten
accord healthcare limited (8093024) - quetiapinfumarat (ph.eur.) - filmtablette - quetiapinfumarat (ph.eur.) (30625) 28,78 milligramm
quetiapin accord 150 mg filmtabletten
accord healthcare limited (8093024) - quetiapinfumarat (ph.eur.) - filmtablette - quetiapinfumarat (ph.eur.) (30625) 172,68 milligramm
quetiapin accord 100 mg filmtabletten
accord healthcare limited (8093024) - quetiapinfumarat (ph.eur.) - filmtablette - quetiapinfumarat (ph.eur.) (30625) 115,12 milligramm
olanzapin accord 10 mg filmtabletten
accord healthcare b.v. - olanzapin -
olanzapin accord 15 mg filmtabletten
accord healthcare b.v. - olanzapin -
olanzapin accord 2,5 mg filmtabletten
accord healthcare b.v. - olanzapin -
olanzapin accord 5 mg filmtabletten
accord healthcare b.v. - olanzapin -